Learn More
Description
Specifications
Specifications
| Antigen | ATP13A2 |
| Applications | Western Blot, Immunohistochemistry |
| Classification | Polyclonal |
| Concentration | 0.75 mg/mL |
| Conjugate | Unconjugated |
| Dilution | Western Blot 2ug/ ml, Simple Western 1:100, Immunohistochemistry 10 ug/ml |
| Formulation | Tris-Glycine and 0.15M NaCl with 0.05% Sodium Azide |
| Gene Accession No. | Q9NQ11 |
| Gene Alias | ATPase type 13A2, EC 3.6.3, EC 3.6.3.-, EC 3.6.3.5, EC 3.6.3.8, FLJ26510, HSA9947, KRPPD, PARK9putative ATPase, Parkinson disease (autosomal recessive) 9 (Kufor-Rakeb syndrome), probable cation-transporting ATPase 13A2 |
| Gene Symbols | ATP13A2 |
| Show More |
For Research Use Only
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
